Aphria Inc. | Balance Sheet

Fiscal year is June-May. All values CAD Millions.
2015
2016
2017
2018
Cash & Short Term Investments
7
16
167
105
Total Accounts Receivable
1
2
6
17
Inventories
2
3
5
29
Other Current Assets
-
-
1
43
Total Current Assets
10
22
179
195
Net Property, Plant & Equipment
4
7
73
303
Total Investments and Advances
-
2
56
51
Long-Term Note Receivable
-
-
1
16
Intangible Assets
-
6
3
749
Total Assets
14
36
318
1,314
ST Debt & Current Portion LT Debt
-
-
2
3
Accounts Payable
1
1
6
32
Income Tax Payable
-
-
-
4
Other Current Liabilities
-
-
3
6
Total Current Liabilities
1
1
10
44
Long-Term Debt
-
-
32
28
Deferred Taxes
-
-
3
59
Other Liabilities
-
-
-
9
Total Liabilities
1
1
44
140
Common Equity (Total)
13
35
274
1,164
Total Shareholders' Equity
13
35
274
1,164
Total Equity
13
35
274
1,174
Liabilities & Shareholders' Equity
14
36
318
1,314
Accumulated Minority Interest
-
-
-
10

About Aphria

View Profile
Address
269 Erie Street West
Leamington Ontario N8H 3C4
Canada
Employees -
Website http://www.aphria.com
Updated 09/14/2018
Aphria, Inc. engages in the production and supply of medical marijuana. Its products include alien dawg, champlian indica, grower's blend, champlain-sativa and blueberry. The company was founded by Cole Cacciavillani and John Cervini on June 22, 2011 and is headquartered in Leamington, Canada.